Skip to main content

Mike Comilla

Head of Investor Relations

Abbott Laboratories (ABT)

Equibles does not estimate personal net worth.

Get an email with a short summary when Abbott Laboratories publishes a filing, an earnings call transcript or a press release.

Get ABT alerts

About Mike Comilla

Mike Comilla is recorded as Head of Investor Relations at Abbott Laboratories (ABT). Mike Comilla has spoken on 9 earnings calls across 1 company, most recently for Abbott Laboratories on October 21, 2026. Abbott Laboratories is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Abbott Laboratories includes Robert B. Ford (CEO, Chairman and Board Member), Philip P. Boudreau (CFO), Robert E. Funck, Jr. (CFO) and 7 others.

Mike Comilla on recent calls

“With me today are Robert Ford, Chairman and Chief Executive Officer, and Phil Boudreaux, Executive Vice President, Finance and Chief Financial officer. Robert and Phil will provide opening remarks.”
Head of Investor Relations, Abbott Laboratories Q3 FY2026 Earnings Call ·
“With me today are Robert Ford, Chairman and Chief Executive Officer, and Phil Boudreaux, Executive Vice President, finance, and chief financial officer. Robert and Phil will provide opening remarks.”
Head of Investor Relations, Abbott Laboratories Q2 FY2026 Earnings Call ·
“With me today are Robert Ford, Chairman and Chief Executive Officer, and Phil Boudreaux, Executive Vice President, Finance and Chief Financial Officer. Robert and Phil will provide opening remarks.”
Head of Investor Relations, Abbott Laboratories Q1 FY2026 Earnings Call ·
“With me today are Robert Ford, Chairman and Chief Executive Officer, and Phil Boudreau, Executive Vice President, Finance and Chief Financial Officer. Robert and Phil will provide opening remarks.”
Head of Investor Relations, Abbott Laboratories Q4 FY2025 Earnings Call ·
“With me today are Robert Ford, Chairman and Chief Executive Officer, and Philip Boudreau, Executive Vice President Finance and Chief Financial Officer. Robert and Philip will provide opening remarks.”
Head of Investor Relations, Abbott Laboratories Q3 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at Abbott Laboratories

Recent activity